Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takashi Shinzato is active.

Publication


Featured researches published by Takashi Shinzato.


Infection and Immunity | 2005

Legionella pneumophila NudA Is a Nudix Hydrolase and Virulence Factor

Paul H. Edelstein; Baofeng Hu; Takashi Shinzato; Martha A. C. Edelstein; WenLian Xu; Maurice J. Bessman

ABSTRACT We studied the identity and function of the 528-bp gene immediately upstream of Legionella pneumophila F2310 ptsP (enzyme INtr). This gene, nudA, encoded for a Nudix hydrolase based on the inferred protein sequence. NudA had hydrolytic activity typical of other Nudix hydrolases, such as Escherichia coli YgdP, in that ApnA’s, in particular diadenosine pentaphosphate (Ap5A), were the preferred substrates. NudA hydrolyzed Ap5A to ATP plus ADP. Both ptsP and nudA were cotranscribed. Bacterial two-hybrid analysis showed no PtsP-NudA interactions. Gene nudA was present in 19 of 20 different L. pneumophila strains tested and in 5 of 10 different Legionella spp. other than L. pneumophila. An in-frame nudA mutation was made in L. pneumophila F2310 to determine the phenotype. The nudA mutant was an auxotroph that grew slowly in liquid and on solid media and had a smaller colony size than its parent. In addition, the mutant was more salt resistant than its parent and grew very poorly at 25°C; all of these characteristics, as well as auxotrophy and slow-growth rate, were reversed by transcomplementation with nudA. The nudA mutant was outcompeted by about fourfold by the parent in competition studies in macrophages; transcomplementation almost completely restored this defect. Competition studies in guinea pigs with L. pneumophila pneumonia showed that the nudA mutant was outcompeted by its parent in both lung and spleen. NudA is of major importance for resisting stress in L. pneumophila and is a virulence factor.


European Journal of Radiology | 2010

Computed tomographic features of 23 sporadic cases with Legionella pneumophila pneumonia

Hui Yu; Futoshi Higa; Kenji Hibiya; Makoto Furugen; Yoko Sato; Takashi Shinzato; Shusaku Haranaga; Satomi Yara; Masao Tateyama; Jiro Fujita; Huiping Li

OBJECTIVE To describe the chest computed tomographic (CT) findings of Legionella pneumophila pneumonia. METHODS CT scans obtained from 23 sporadic cases of L. pneumophila pneumonia were retrospectively reviewed. Chest CT findings were analyzed with regard to the patterns and distributions of pulmonary abnormalities. We also analyzed the histopathology of lungs from guinea pigs with experimentally induced L. pneumophila pneumonia. RESULTS Consolidation and ground-glass opacity (GGO) were the main findings of CT scans in L. pneumophila pneumonia. The distribution of opacities was categorized as non-segmental (n=20) and segmental (n=4). Non-segmental distribution may follow an onset of segmental distribution. Pleural effusion was observed in 14 (58.3%) patients, of which 13 were accompanied with non-segmental distribution. Abscess formation was observed in only one immunocompromised patient. In the animal pneumonia model, the lesions comprised of terminal bronchioles, alveolar spaces, and interstitia. Small bacilli were observed to be contained by many macrophages within the alveoli. CONCLUSION Non-segmental distribution was significantly more frequent than segmental distribution in L. pneumophila pneumonia. It is possible that L. pneumophila infection initially results in segmental pneumonia, which progresses to typical non-segmental distribution.


Journal of Medical Microbiology | 2018

A hemin auxotrophic Enterobacter cloacae clinical isolate with increased resistance to carbapenems and aminoglycosides

Tatsuya Tada; Kohei Uechi; Isamu Nakasone; Zenji Miyazato; Takashi Shinzato; Kayo Shimada; Mitsuhiro Tsuchiya; Teruo Kirikae; Jiro Fujita

Small-colony variants (SCVs) were obtained from an Enterobacter cloacae clinical isolate in Okinawa, Japan. One variant showed auxotrophy for hemin with a deletion of 20 365 nucleotides, dosC-ydiK-mmuP-mmuM-tauA-tauB-tauC-tauD-hemB-yaiT-yaiV-ampH-yddQ-sbmA-yaiW-yaiY-yaiZ, including hemB, and was more resistant to aminoglycosides and carbapenems, but more susceptible to aztreonam, than the parent strain.


Internal Medicine | 2015

Falciparum Malaria Incidentally Pretreated with Azithromycin

Daisuke Shibahara; Takeshi Kinjo; Naoya Nishiyama; Wakaki Kami; Daijiro Nabeya; Shusaku Haranaga; Futoshi Higa; Masao Tateyama; Takashi Shinzato; Hiromu Toma; Hidehiro Kishimoto; Jiro Fujita

A 65-year-old man, who recently returned from Liberia, visited a clinic complaining of fever, and azithromycin was prescribed. The patient presented to a general hospital 5 days after the onset of symptoms, however, a blood smear examination failed to detect malaria. Contrary to the blood smear result, a rapid antigen test in our hospital was strongly-positive for falciparum malaria, indicating a high level of malarial antigen in the blood. Moreover, laboratory examinations on admission showed a tendency for improvement. We assumed that the administration of azithromycin partially treated malaria, thus complicating the blood smear diagnosis. We should be careful in prescribing azithromycin, which is widely used in clinics, to travelers returning from malaria-endemic countries.


Clinical Infectious Diseases | 1995

The Streptococcus milleri Group as a Cause of Pulmonary Infections

Takashi Shinzato; Atsushi Saito


American Journal of Respiratory and Critical Care Medicine | 2003

High Plasma Osteopontin Level and Its Relationship with Interleukin-12–mediated Type 1 T Helper Cell Response in Tuberculosis

Yoshinobu Koguchi; Kazuyoshi Kawakami; Kaori Uezu; Kiyoyasu Fukushima; Sigeyuki Kon; Masahiro Maeda; Atsushi Nakamoto; Isoko Owan; Mutsuo Kuba; Norifumi Kudeken; Masato Azuma; Satomi Yara; Takashi Shinzato; Futoshi Higa; Masao Tateyama; Jun-ichi Kadota; Hiroshi Mukae; Shigeru Kohno; Toshimitsu Uede; Atsushi Saito


Internal Medicine | 2004

Pulmonary strongyloidiasis in a patient receiving prednisolone therapy.

Shun Namisato; Kazuhisa Motomura; Shusaku Haranaga; Tetsuo Hirata; Masato Toyama; Takashi Shinzato; Futoshi Higa; Atsushi Saito


Antimicrobial Agents and Chemotherapy | 2001

In Vitro Activity of Gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and Its Pharmacokinetics in Guinea Pigs with L. pneumophila Pneumonia

Paul H. Edelstein; Takashi Shinzato; Edward Doyle; Martha A. C. Edelstein


Journal of Infection and Chemotherapy | 2004

The role of the capsule of the Streptococcus milleri group in its pathogenicity

Shuzo Kanamori; Nobuchika Kusano; Takashi Shinzato; Atsushi Saito


International Journal of Antimicrobial Agents | 2006

In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus

Natsuo Yamamoto; Jiro Fujita; Takashi Shinzato; Futoshi Higa; Masao Tateyama; Masato Tohyama; Isamu Nakasone; Nobuhisa Yamane

Collaboration


Dive into the Takashi Shinzato's collaboration.

Top Co-Authors

Avatar

Futoshi Higa

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Atsushi Saito

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Masao Tateyama

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michio Koide

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Jiro Fujita

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Isamu Nakasone

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Masato Tohyama

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Noriko Arakaki

University of the Ryukyus

View shared research outputs
Researchain Logo
Decentralizing Knowledge